Genome-guided discovery of cancer therapeutic targets

Summary: The success of precision oncology—which aims to match the right therapies to the right patients based on molecular status—is predicated on a robust pipeline of molecular targets against which therapies can be developed. Recent advances in genomics and functional genetics have enabled the un...

Full description

Bibliographic Details
Published in:Cell Reports
Main Authors: Prathyusha Konda, Simon Garinet, Eliezer M. Van Allen, Srinivas R. Viswanathan
Format: Article
Language:English
Published: Elsevier 2023-08-01
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124723009890
_version_ 1850295219453427712
author Prathyusha Konda
Simon Garinet
Eliezer M. Van Allen
Srinivas R. Viswanathan
author_facet Prathyusha Konda
Simon Garinet
Eliezer M. Van Allen
Srinivas R. Viswanathan
author_sort Prathyusha Konda
collection DOAJ
container_title Cell Reports
description Summary: The success of precision oncology—which aims to match the right therapies to the right patients based on molecular status—is predicated on a robust pipeline of molecular targets against which therapies can be developed. Recent advances in genomics and functional genetics have enabled the unbiased discovery of novel molecular targets at scale. We summarize the promise and challenges in integrating genomic and functional genetic landscapes of cancer to establish the next generation of cancer targets.
format Article
id doaj-art-e2a9b918547f404dbffa2454a9fc8ff9
institution Directory of Open Access Journals
issn 2211-1247
language English
publishDate 2023-08-01
publisher Elsevier
record_format Article
spelling doaj-art-e2a9b918547f404dbffa2454a9fc8ff92025-08-19T23:33:36ZengElsevierCell Reports2211-12472023-08-0142811297810.1016/j.celrep.2023.112978Genome-guided discovery of cancer therapeutic targetsPrathyusha Konda0Simon Garinet1Eliezer M. Van Allen2Srinivas R. Viswanathan3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USADepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USADepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USADepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA; Corresponding authorSummary: The success of precision oncology—which aims to match the right therapies to the right patients based on molecular status—is predicated on a robust pipeline of molecular targets against which therapies can be developed. Recent advances in genomics and functional genetics have enabled the unbiased discovery of novel molecular targets at scale. We summarize the promise and challenges in integrating genomic and functional genetic landscapes of cancer to establish the next generation of cancer targets.http://www.sciencedirect.com/science/article/pii/S2211124723009890CP: Cancer
spellingShingle Prathyusha Konda
Simon Garinet
Eliezer M. Van Allen
Srinivas R. Viswanathan
Genome-guided discovery of cancer therapeutic targets
CP: Cancer
title Genome-guided discovery of cancer therapeutic targets
title_full Genome-guided discovery of cancer therapeutic targets
title_fullStr Genome-guided discovery of cancer therapeutic targets
title_full_unstemmed Genome-guided discovery of cancer therapeutic targets
title_short Genome-guided discovery of cancer therapeutic targets
title_sort genome guided discovery of cancer therapeutic targets
topic CP: Cancer
url http://www.sciencedirect.com/science/article/pii/S2211124723009890
work_keys_str_mv AT prathyushakonda genomeguideddiscoveryofcancertherapeutictargets
AT simongarinet genomeguideddiscoveryofcancertherapeutictargets
AT eliezermvanallen genomeguideddiscoveryofcancertherapeutictargets
AT srinivasrviswanathan genomeguideddiscoveryofcancertherapeutictargets